Headlines about R1 RCM (NASDAQ:RCM) have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. R1 RCM earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 45.3646742217858 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Shares of R1 RCM (NASDAQ:RCM) traded up $0.05 on Tuesday, reaching $3.70. The company’s stock had a trading volume of 101,900 shares, compared to its average volume of 383,181. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of -0.03. R1 RCM has a 12-month low of $2.02 and a 12-month high of $4.37.
About R1 RCM
R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.
Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with MarketBeat.com's FREE daily email newsletter.